Status:
TERMINATED
Study In Asthma Control
Lead Sponsor:
GlaxoSmithKline
Conditions:
Asthma
Eligibility:
All Genders
12+ years
Phase:
PHASE4
Brief Summary
This study will compare patients treated with a marketed medication and those who continue with their usual care to assess the proportion of patients achieving well controlled asthma after 24 weeks.
Eligibility Criteria
Inclusion
- documented clinical history of asthma and receiving regular maintenance therapy.
Exclusion
- Using oral/parenteral or depot corticosteroids within 12 weeks of visit 1.
- History of heavy smoking or substance abuse.
- Females who are pregnant or lactating.
- Required emergency room treatment for their asthma 12 weeks prior to Visit 1.
- Serious, uncontrolled, systemic disease that may make study participation unsafe or inappropriate in the opinion of the physician.
- Other medical criteria will be evaluated at the screening visit.
Key Trial Info
Start Date :
November 8 2004
Trial Type :
INTERVENTIONAL
End Date :
March 28 2006
Estimated Enrollment :
680 Patients enrolled
Trial Details
Trial ID
NCT00273026
Start Date
November 8 2004
End Date
March 28 2006
Last Update
March 21 2018
Active Locations (132)
Enter a location and click search to find clinical trials sorted by distance.
1
GSK Investigational Site
Calgary, Alberta, Canada, T3C 3P1
2
GSK Investigational Site
Calgary, Alberta, Canada, T3E 7C4
3
GSK Investigational Site
Edmonton, Alberta, Canada, T5A 4L8
4
GSK Investigational Site
Edmonton, Alberta, Canada, T5C OA3